BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23732194)

  • 1. [Utility of 11C-methionine PET/CT in neuro-oncology].
    Casas Parera I; Igirio Gamero JL; Blumenkrantz Y; Bruno G; Báez A; Tafur Canabal JG; Báez M; Kuchkaryan V
    Medicina (B Aires); 2013; 73(3):201-6. PubMed ID: 23732194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
    D'Souza MM; Sharma R; Jaimini A; Panwar P; Saw S; Kaur P; Mondal A; Mishra A; Tripathi RP
    Clin Nucl Med; 2014 Sep; 39(9):791-8. PubMed ID: 25036022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.
    Ninatti G; Sollini M; Bono B; Gozzi N; Fedorov D; Antunovic L; Gelardi F; Navarria P; Politi LS; Pessina F; Chiti A
    Neuro Oncol; 2022 Sep; 24(9):1546-1556. PubMed ID: 35171292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors.
    Schinkelshoek M; Lopci E; Clerici E; Alongi F; Mancosu P; Rodari M; Navarria P; van der Hiel B; Scorsetti M; Chiti A
    Tumori; 2014; 100(6):636-44. PubMed ID: 25688497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.
    Hara T; Kondo T; Hara T; Kosaka N
    J Neurosurg; 2003 Sep; 99(3):474-9. PubMed ID: 12959432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
    Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S
    Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography.
    Shinozaki N; Uchino Y; Yoshikawa K; Matsutani T; Hasegawa A; Saeki N; Iwadate Y
    J Neurosurg; 2011 Jun; 114(6):1640-7. PubMed ID: 21214332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
    Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
    Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.
    Ericson K; Lilja A; Bergström M; Collins VP; Eriksson L; Ehrin E; von Holst H; Lundqvist H; Långsrom B B; Mosskin M
    J Comput Assist Tomogr; 1985; 9(4):683-9. PubMed ID: 3926834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study on EGFR-targeted molecular imaging of PET/CT With 11C-PD153035 in human gliomas.
    Sun J; Cai L; Zhang K; Zhang A; Pu P; Yang W; Gao S
    Clin Nucl Med; 2014 Jan; 39(1):e20-6. PubMed ID: 24335566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral glioma: evaluation with methionine PET.
    Ogawa T; Shishido F; Kanno I; Inugami A; Fujita H; Murakami M; Shimosegawa E; Ito H; Hatazawa J; Okudera T
    Radiology; 1993 Jan; 186(1):45-53. PubMed ID: 8380108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
    Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
    J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamic11C-methionine PET/CT in differential diagnosis of brain gliomas].
    Vikhrova NB; Kalaeva DB; Postnov AA; Khokhlova EV; Konakova TA; Batalov AI; Pogosbekyan EL; Pronin IN
    Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(3):5-13. PubMed ID: 34156203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
    Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
    Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.